Latest ARCH VENTURE CORP Stock Portfolio
$1.10Billion | No. of Holdings #12
ARCH VENTURE CORP Performance
2026 Q2+10.92%
YTD+17.03%
2025+73.87%
About ARCH VENTURE CORP and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $1.1 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of ARCH Venture Management, LLC are , BEAM, . The fund has invested 15.9% of it's portfolio in PARABILIS MEDICINES INC and 14.2% of portfolio in BEAM THERAPEUTICS INC. <br><br> The fund managers got completely rid off Q32 BIO INC stocks. They significantly reduced their stock positions in VIR BIOTECHNOLOGY INC (VIR). ARCH Venture Management, LLC opened new stock positions in PARABILIS MEDICINES INC.
ARCH VENTURE CORP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$1.10Billion
as of Aug 14, 2026ARCH VENTURE CORP Annual Return Estimates Vs S&P 500
Our best estimate is that ARCH Venture Management, LLC made a return of 10.92% in the last quarter. In trailing 12 months, it's portfolio return was 158.62%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| parabilis medicines inc | 175,518,000 |
| seaport therapeutics inc | 136,600,000 |
| boundless bio inc | 6,735,240 |
New stocks bought by ARCH VENTURE CORP
Additions
No additions were made to existing positions by ARCH VENTURE CORP
Reductions
| Ticker | % Reduced |
|---|---|
| vir biotechnology inc | -1.72 |
ARCH VENTURE CORP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| q32 bio inc | -2,057,490 |
ARCH VENTURE CORP got rid off the above stocks
Sector Distribution
ARCH Venture Management, LLC has about 57.3% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 57.3 |
| Healthcare | 42.7 |
Market Cap. Distribution
ARCH Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
| Category | % |
|---|---|
| UNALLOCATED | 57.3 |
| MID-CAP | 26.7 |
| SMALL-CAP | 15.9 |
Stocks belong to which Index?
About 41.9% of the stocks held by ARCH Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 58.1 |
| RUSSELL 2000 | 41.9 |
ARCH VENTURE CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ARCH VENTURE CORP
ARCH Venture Management, LLC has 12 stocks in it's portfolio. LYEL proved to be the most loss making stock for the portfolio. BEAM was the most profitable stock for ARCH Venture Management, LLC last quarter.
$1.10BTotal Value
13.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Beam Therapeutics Inc ARCH VENTURE CORP's holding in Beam Therapeutics Inc over time | 14.16% | 4,540,130 | $155.77M 14.16% | 0%unchanged 0 percentunchanged | |
 Erasca Inc Erasca IncERAS ARCH VENTURE CORP's holding in Erasca Inc over time | 11.81% | 7,091,560 | $129.92M 11.81% | 0%unchanged 0 percentunchanged | |
 Gossamer Bio Inc Gossamer Bio IncGOSS ARCH VENTURE CORP's holding in Gossamer Bio Inc over time | 0.12% | 8,055,920 | $1.33M 0.12% | 0%unchanged 0 percentunchanged | |
 Lyell Immunopharma Inc ARCH VENTURE CORP's holding in Lyell Immunopharma Inc over time | 4.14% | 3,247,160 | $45.53M 4.14% | 0%unchanged 0 percentunchanged | |
 10x Genomics Inc ARCH VENTURE CORP's holding in 10x Genomics Inc over time | 0.76% | 217,834 | $8.35M 0.76% | 0%unchanged 0 percentunchanged | |
 Vir Biotechnology Inc ARCH VENTURE CORP's holding in Vir Biotechnology Inc over time | 11.76% | 12,694,200 | $129.35M 11.76% | 1.72%decreased 1.72 percentreduced | |
Com Parabilis Medicines IncParabilis Medicines Inc | 15.95% | 6,412,780 | $175.52M 15.95% | Newnew position | |
Com Rapport Therapeutics IncRapport Therapeutics Inc | 14.12% | 3,728,740 | $155.38M 14.12% | 0%unchanged 0 percentunchanged | |
Common Stock Seaport Therapeutics IncSeaport Therapeutics Inc | 12.41% | 6,294,950 | $136.60M 12.41% | Newnew position | |
Com Maze Therapeutics IncMaze Therapeutics Inc | 11.18% | 4,120,050 | $122.98M 11.18% | 0%unchanged 0 percentunchanged | |
Com Shs Generate Biomedicines IncGenerate Biomedicines Inc | 2.98% | 1,944,430 | $32.80M 2.98% | 0%unchanged 0 percentunchanged | |
Com Boundless Bio IncBoundless Bio Inc | 0.61% | 2,694,100 | $6.74M 0.61% | Newnew position | |
Com Q32 Bio IncQ32 Bio Inc | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |